Former Educator Touts Strong Legislative Affairs Background
Client Service, Business Growth Remain Top Priority
Five members of McGuireWoods Consulting’s Atlanta office were recognized in the James Magazine’s 2018 “Top Lobbyist” issue.
Chris Nolen, a senior vice president in McGuireWoods Consulting’s state government relations practice, recently received administration appointments by Virginia Gov. Ralph Northam and Virginia House of Delegates Speaker Kirk Cox.
McGuireWoods Consulting’s in-house advocacy and mobilization team, MWCAdvocacy, continues to grow, strategically expanding its depth of experience. This summer, three new hires were made to address specific client needs.
This Week: Labor-HHS funding approved by Senate in “minibus”; Grassley looks at nursing home data on preventable errors; FDA announces penalties for researchers if false or partial data submitted; “Public Charge” rule proposed.
Your weekly North Carolina political news report.
The Raleigh office sends thoughts and prayers across the state of North Carolina in the aftermath of Hurricane Florence. While we may not know the full extent of the storm's impact for weeks, know that we are here to serve in whatever way that we can. We wish everyone a successful recovery and safe travels during this time.
Governor Cooper has called a special session for October 9. The General Assembly says it is prepared to take up matters pertaining to disaster relief funds.
This Week: Advent of 5G Attracts Increased Attention from Policymakers | Senate Homeland Security Committee Examines Evolving Threats | FTC Kicks Off Hearings on Competition and Consumer Protection in the 21st Century | Credit Card Companies, Banks Reach Settlement in Decade-Long Swipe Fee Dispute
An overview of the upcoming week in Congress from the McGuireWoods Consulting Federal Public Affairs Team.
The Centers for Medicare and Medicaid Services (CMS) recently proposed to expand its site-neutral payment policy to clinic visits.
The House of Representatives approved the first major change to federal regulation of the over-the-counter drug industry in 40 years.